Claim
In the testing cohort, PANXEON combined with CA19-9 detected stage I–II pancreatic ductal adenocarcinoma with 86.8% sensitivity, with false-positive rates of 3.2% in low-risk controls and 15.6% in high-risk controls.
30 words; atomic claims are usually under 25a conjunction joins clauses that may be separately evaluablea comma-separated series may list several propositionsTopics
Medicine · 1efd24fe Health · 1efd24fe
Assessment
Supported
Main unresolved issue: 4 counted evidence items have no independence review; repeats of one origin may be counted as several coverage:78de54be-827c-8f56-8c80-fecdff28a421
Not yet independently audited.Evidence reviewed so far supports this claim, but only 1 of 4 review checks has been done.Every quoted passage was confirmed on the page when Galedra fetched it.
Why?
Strongest counted support: The passage directly reports 86.8% sensitivity and the 3.2% and 15.6% false-positive rates for the testing cohort. weight 1.800000 evidence
Suppressed as dependent: The primary paper reports 86.8% sensitivity for stage I–II PDAC and false-positive rates of 3.2% and 15.6% in the stated control groups.; Cancer Network independently reports the same testing-cohort performance figures for the PANXEON composite.
Review gaps: qualifiers reviewed, opposing search done, independence reviewed
What would most change this: One independent, direct measurement that contradicts this claim would move it from Supported to Supported.
0.9908 under ledger-default@0.3.0 at snapshot 27745 · state Supported · Review checks: 1 of 4 · stability HIGH · 6 sources, 3 independent lineages
How the number was reached
| Link | Working | Weight | Counted as |
|---|---|---|---|
| b659b8f1 support | relevance STRONG 1.2 × observation DIRECT_TEXT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 1.080000 | 1.080000 |
| c98eb782 qualify | relevance DIRECT 2.0 × observation MEASUREMENT 1.0 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 2.000000 | 0.000000 (non directional) |
| 4bcfc24a support | relevance DIRECT 2.0 × observation DIRECT_TEXT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 1.800000 | 0.000000 (dependent strongest only, kept 50cdf67f) |
| 0e5beb23 support | relevance DIRECT 2.0 × observation DATASET_RESULT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 1.800000 | 0.000000 (dependent strongest only, kept dfe17fbf) |
| 50cdf67f support | relevance DIRECT 2.0 × observation DATASET_RESULT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 1.800000 | 1.800000 |
| dfe17fbf support | relevance DIRECT 2.0 × observation DATASET_RESULT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 1.800000 | 1.800000 |
prior 0.50 → log-odds 0.000000 + 4.680000 (the counted weights) = 4.680000 → probability 0.9908
Your view
Registered views
Nobody has registered a view yet.
Checked as part of
- “In the testing cohort, PANXEON combined with CA19-9 detected stage I–II pancreatic ductal adenocarcinoma with 86.8% sensitivity, with false-positive rates of...” · 1 claim · 29 September 2026
- “In the testing cohort, PANXEON combined with CA19-9 detected stage I–II pancreatic ductal adenocarcinoma with 86.8% sensitivity, with false-positive rates of...” · 1 claim · 28 September 2026
- “In an international prospective biomarker study, the PANXEON blood assay combined with CA19-9 detected stage I–II pancreatic ductal adenocarcinoma with 86.8%...” · 1 claim · 28 September 2026
Evidence for
-
From Liquid biopsy for early detection of pancreatic ductal adenocarcinoma Read 2026-09-28 Relevance DIRECT Steps 0 Counted
-
From PANXEON Liquid Biopsy Demonstrates Potential for Detecting Early Pancreatic Cancer Read 2026-09-28 Relevance DIRECT Steps 0 Counted
-
From New Study: Blood Test Shows Promise for Detecting Pancreatic Cancer at Its Earliest Stages Read 2026-09-28 Relevance STRONG Steps 0 Counted
Institutional summary independently rounds the study’s 86.8%, 3.2%, and 15.6% testing-cohort figures.
-
From Liquid biopsy for early detection of pancreatic ductal adenocarcinoma Read 2026-09-28 Relevance DIRECT Steps 0 Counted
-
From Liquid biopsy for early detection of pancreatic ductal adenocarcinoma Read 2026-09-29 Relevance DIRECT Steps 0 Counted
Primary Nature Medicine evidence directly confirms the existing quantitative claim.
Evidence against
None.
Qualifications
-
From Liquid biopsy for early detection of pancreatic ductal adenocarcinoma Read 2026-09-28 Relevance DIRECT Steps 0 Counted
The sampling and control-group scope materially limits generalization beyond the reported cohort.
Suppressed as dependent
| Evidence | Group | Kept instead |
|---|---|---|
| da938f94 | 50cdf67f | |
| 23b0ee43 | 95aaa2eb | dfe17fbf |
Inferences
Concluded from
None.
Used as a premise in
None.
Threads
None. Threads are for disagreements about how a determination was made — a statement whose figures are not in the passage it rests on, two sources that may share an origin. Something about the world belongs in the evidence above.
Claim edges
| From | Relationship | To |
|---|---|---|
| 68c78451 | NARROWS | ff28a421 |
Review checklist
Review checks: 1 of 4
| Check | Done | By |
|---|---|---|
| qualifiers reviewed | no | |
| opposing search done | no | |
| independence reviewed | no | |
| primary source reviewed | yes | c98eb782, 4bcfc24a, 50cdf67f, dfe17fbf |
Summary
Supported. The main support is: City of Hope reports roughly 87% stage I–II detection with 3% and 16% false-positive rates in low- and high-risk groups. d6b01c12
2 further items repeat the same origin and are not independent evidence. 95aaa2eb
Qualifier: The source explicitly labels the figures as testing-cohort results and separates low-risk from high-risk controls. 2cf404c1
A narrower version of this claim is supported. 68c78451
Review checks: 1 of 4. coverage:78de54be-827c-8f56-8c80-fecdff28a421
Contribution history
| seq | event | detail |
|---|---|---|
| 14178 | APPENDED | |
| 14179 | ACCEPT | AUTOMATIC_AFTER_VALIDATION |
| 14186 | LINK_EVIDENCE | by 1efd24fe (accepted) |
| 14188 | LINK_EVIDENCE | by 1efd24fe (accepted) |
| 14203 | LINK_EVIDENCE | by 1efd24fe (accepted) |
| 14205 | TASK_RESULT | by 1efd24fe (accepted) |
| 14215 | TASK_RESULT | by 1efd24fe (accepted) |
| 20778 | LINK_EVIDENCE | by 1efd24fe (accepted) |
Score trace
{
"claim": "78de54be-827c-8f56-8c80-fecdff28a421",
"links": [
{
"link": "03732f76-9261-8c32-9c64-2a29b659b8f1",
"group": null,
"edition": "NAMED_OR_UNRELATED",
"evidence": "b211e960-0fd8-8817-aaaa-79cbd6b01c12",
"direction": "SUPPORT",
"magnitude": "1.080000",
"relevance": "STRONG",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DIRECT_TEXT",
"source_type": "SECONDARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "1.080000",
"interpretive_steps": 0
},
{
"link": "537b4678-718a-8654-babe-6cb3c98eb782",
"group": null,
"reason": "non_directional",
"edition": "NAMED_OR_UNRELATED",
"evidence": "8eae202b-3b15-88b5-a05f-704e2cf404c1",
"direction": "QUALIFY",
"magnitude": "2.000000",
"relevance": "DIRECT",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "MEASUREMENT",
"source_type": "PRIMARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "0.000000",
"interpretive_steps": 0
},
{
"kept": "d78dbb22-43a4-8136-82c8-16b650cdf67f",
"link": "68a78fd3-d300-8c9d-b9f6-a5e44bcfc24a",
"group": null,
"reason": "dependent_strongest_only",
"edition": "NAMED_OR_UNRELATED",
"evidence": "9c12dcc8-672a-85d4-a40d-56a0da938f94",
"direction": "SUPPORT",
"magnitude": "1.800000",
"relevance": "DIRECT",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DIRECT_TEXT",
"source_type": "PRIMARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "0.000000",
"interpretive_steps": 0
},
{
"kept": "f8759185-9eac-83e1-a030-7c35dfe17fbf",
"link": "6ba46a12-de09-888d-9dd9-83e50e5beb23",
"group": "94aba2df-fd8a-81bc-ae9c-152f95aaa2eb",
"reason": "dependent_strongest_only",
"edition": "NAMED_OR_UNRELATED",
"evidence": "68650a4b-12b6-8ce7-9647-2d1723b0ee43",
"direction": "SUPPORT",
"magnitude": "1.800000",
"relevance": "DIRECT",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DATASET_RESULT",
"source_type": "SECONDARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "0.000000",
"interpretive_steps": 0
},
{
"link": "d78dbb22-43a4-8136-82c8-16b650cdf67f",
"group": null,
"edition": "NAMED_OR_UNRELATED",
"evidence": "d3c3155b-28c5-8443-a642-00e9598274a0",
"direction": "SUPPORT",
"magnitude": "1.800000",
"relevance": "DIRECT",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DATASET_RESULT",
"source_type": "PRIMARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "1.800000",
"interpretive_steps": 0
},
{
"link": "f8759185-9eac-83e1-a030-7c35dfe17fbf",
"group": "94aba2df-fd8a-81bc-ae9c-152f95aaa2eb",
"edition": "NAMED_OR_UNRELATED",
"evidence": "9ccc07dc-54e3-89a7-b0ce-0b02fca40448",
"direction": "SUPPORT",
"magnitude": "1.800000",
"relevance": "DIRECT",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DATASET_RESULT",
"source_type": "PRIMARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "1.800000",
"interpretive_steps": 0
}
],
"model": "ledger-default@0.3.0",
"prior": "0.50",
"variants": {
"spread": "0.0341",
"permissive": "0.9977",
"conservative": "0.9636"
},
"code_hash": "sha256:c61a6fdf35a754a0d7e958df149036a083c0eaeb7d2d2e52704ec32b0c36def7",
"contested": false,
"stability": "HIGH",
"claim_type": "QUANTITATIVE",
"config_hash": "sha256:86768038080b8ab5233f1e4b7aba10af05b5bb44caa432095150b90e81209809",
"probability": "0.9908",
"provisional": true,
"evidence_sum": "4.680000",
"snapshot_seq": 20779,
"prior_log_odds": "0.000000",
"support_groups": 3,
"model_dependent": false,
"review_coverage": "0.25",
"truth_evaluable": true,
"assessment_state": "SUPPORTED",
"review_checklist": {
"qualifiers_reviewed": {
"by": [],
"ok": false
},
"opposing_search_done": {
"by": [],
"ok": false
},
"independence_reviewed": {
"by": [],
"ok": false
},
"primary_source_reviewed": {
"by": [
"537b4678-718a-8654-babe-6cb3c98eb782",
"68a78fd3-d300-8c9d-b9f6-a5e44bcfc24a",
"d78dbb22-43a4-8136-82c8-16b650cdf67f",
"f8759185-9eac-83e1-a030-7c35dfe17fbf"
],
"ok": true
}
},
"contradict_groups": 0,
"rounding_boundary": false,
"posterior_log_odds": "4.680000",
"not_applicable_reason": null,
"independence_unreviewed": 4
}